Morbidity of cholecystectomy and gastric bypass in a national database. BJS 2018; 105: 121-127.
Published: 18th October 2017
Authors: V. Wanjura, E. Szabo, J. Österberg, J. Ottosson, L. Enochsson, G. Sandblom et al.
There is a strong association between obesity and gallstones. However, there is no clear evidence regarding the optimal order of Roux‐en‐Y gastric bypass (RYGB) and cholecystectomy when both procedures are clinically indicated.
Based on cross‐matched data from the Swedish Register for Cholecystectomy and Endoscopic Retrograde Cholangiopancreatography (GallRiks; 79 386 patients) and the Scandinavian Obesity Surgery Registry (SOReg; 36 098 patients) from 2007 to 2013, complication rates, reoperation rates and operation times related to the timing of RYGB and cholecystectomy were explored.
There was a higher aggregate complication risk when cholecystectomy was performed after RYGB rather than before (odds ratio (OR) 1·35, 95 per cent c.i. 1·09 to 1·68;
Cholecystectomy should be performed before, not during or after, RYGB.Read more
You may also be interested in
[18F]Fluorodeoxyglucose PET/CT and prediction of histopathological response to neoadjuvant chemotherapy for adenocarcinoma of the oesophagus and oesophagogastric junction.
Authors: T. Harustiak, M. Zemanova, P. Fencl, L. Hornofova, A. Pazdro, M. Snajdauf et al.
Notes: Of no use
Authors: M. Gelli, M. A. Allard, O. Farges, C. Paugam‐Burtz, J. Y. Mabrut, J. M. Regimbeau et al.
Notes: No increased risk
Meta‐analysis of delayed gastric emptying after pylorus‐preserving versus pylorus‐resecting pancreatoduodenectomy.
Authors: U. Klaiber, P. Probst, O. Strobel, C. W. Michalski, C. Dörr‐Harim, M. K. Diener et al.
Notes: No difference
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra‐appendicular origin.
Authors: J.‐B. Delhorme, F. Severac, G. Averous, O. Glehen, G. Passot, N. Bakrin et al.
Notes: Survival similar
Intrathoracic versus cervical anastomosis and predictors of anastomotic leakage after oesophagectomy for cancer.
Authors: J. A. H. Gooszen, L. Goense, S. S. Gisbertz, J. P. Ruurda, R. van Hillegersberg, M. I. van Berge Henegouwen et al.
Notes: Chest lower leak rates
Meta‐analysis of mortality in patients with high‐risk intraductal papillary mucinous neoplasms under observation.
Authors: G. Vanella, S. Crippa, L. Archibugi, P. G. Arcidiacono, G. Delle Fave, M. Falconi et al.
Notes: Low disease‐related mortality
Randomized clinical trial
Randomized clinical trial of intraoperative parathyroid gland angiography with indocyanine green fluorescence predicting parathyroid function after thyroid surgery.
Authors: J. Vidal Fortuny, S. M. Sadowski, V. Belfontali, S. Guigard, A. Poncet, F. Ris et al.
Notes: Simplifies post‐op monitoring
Authors: P. Studer, T. Horn, A. Haynes, D. Candinas, V. M. Banz
Surgeon volume and prognosis of patients with advanced papillary thyroid cancer and lateral nodal metastasis. BJS 2018; 105: 270-278.
Authors: H. I. Kim, T. H. Kim, J.‐H. Choe, J.‐H. Kim, J. S. Kim, Y. N. Kim et al.
Notes: Volume is key
Randomized clinical trial
Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer. BJS 2018; 105: 192-202.
Authors: T. Ebata, S. Hirano, M. Konishi, K. Uesaka, Y. Tsuchiya, M. Ohtsuka et al.
Notes: No advantage
Effect of parathyroidectomy on quality of life and non‐specific symptoms in normocalcaemic primary hyperparathyroidism. BJS 2018; 105: 223-229.
Authors: S. Bannani, N. Christou, C. Guérin, A. Hamy, F. Sebag, M. Mathonnet et al.
Notes: Little improvement